Pages that link to "Q28252750"
Jump to navigation
Jump to search
The following pages link to Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer (Q28252750):
Displaying 50 items.
- Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis (Q26796554) (← links)
- Stem cells, colorectal cancer and cancer stem cell markers correlations (Q26823217) (← links)
- CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis (Q26827628) (← links)
- Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies (Q26995698) (← links)
- Cancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectives (Q27024651) (← links)
- P21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer (Q27852992) (← links)
- Molecular and pathogenetic aspects of tumor budding in colorectal cancer (Q28085313) (← links)
- Establishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cells (Q28539620) (← links)
- Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy (Q31123584) (← links)
- Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma (Q33582684) (← links)
- Distinct patterns of ALDH1A1 expression predict metastasis and poor outcome of colorectal carcinoma (Q33898776) (← links)
- Prognostic significance of CD44 variant 2 upregulation in colorectal cancer (Q33918070) (← links)
- Cancerous stem cells: deviant stem cells with cancer-causing misbehavior (Q33999466) (← links)
- Colorectal cancers mimic structural organization of normal colonic crypts (Q34027850) (← links)
- Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer. (Q34059673) (← links)
- Toponome Imaging System: In Situ Protein Network Mapping in Normal and Cancerous Colon from the Same Patient Reveals More than Five-Thousand Cancer Specific Protein Clusters and Their Subcellular Annotation by Using a Three Symbol Code (Q34136457) (← links)
- Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics (Q34279411) (← links)
- ALCAM (CD166) expression and serum levels in pancreatic cancer (Q34321201) (← links)
- Prognostic role of CD133 expression in colorectal cancer: a meta-analysis (Q34502600) (← links)
- Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma (Q34511523) (← links)
- Prognostic value of CD166 expression in cancers of the digestive system: a systematic review and meta-analysis (Q34936453) (← links)
- Proteomic Characterization of Cerebrospinal Fluid from Ataxia-Telangiectasia (A-T) Patients Using a LC/MS-Based Label-Free Protein Quantification Technology (Q35432364) (← links)
- ALCAM: Basis Sequence: Mouse (Q35609716) (← links)
- High-level expression of stem cell marker CD133 in clear cell renal cell carcinoma with favorable prognosis (Q36121660) (← links)
- Co-expression of CXCR4 and CD133 proteins is associated with poor prognosis in stage II-III colon cancer patients (Q36225000) (← links)
- Auraptene and its effects on the re-emergence of colon cancer stem cells (Q36392839) (← links)
- CD166(pos) subpopulation from differentiated human ES and iPS cells support repair of acute lung injury. (Q36460474) (← links)
- Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients. (Q36523671) (← links)
- The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44. (Q36545318) (← links)
- Intragenic G-quadruplex structure formed in the human CD133 and its biological and translational relevance (Q36627895) (← links)
- Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas (Q36661089) (← links)
- Cancer stem cells and their role in metastasis (Q36698757) (← links)
- The hyaluronic acid receptor CD44 coordinates normal and metaplastic gastric epithelial progenitor cell proliferation (Q36890737) (← links)
- Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer (Q36946578) (← links)
- CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis (Q36962860) (← links)
- The association between CD166 detection rate and clinicopathologic parameters of patients with colorectal cancer (Q37345963) (← links)
- Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A. (Q37397814) (← links)
- Fibronectin extra domain A (EDA) sustains CD133( )/CD44( ) subpopulation of colorectal cancer cells (Q37566991) (← links)
- Molecular characteristics of colorectal serrated polyps and hyperplastic polyps: A STROBE compliant article (Q37606161) (← links)
- MiR-139-5p reverses CD44 /CD133 -associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells (Q37688905) (← links)
- Anti-EGFR antibody sensitizes colorectal cancer stem-like cells to Fluorouracil-induced apoptosis by affecting autophagy (Q37697172) (← links)
- Colon cancer stem cells: implications in carcinogenesis (Q37825224) (← links)
- The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade (Q37826351) (← links)
- The Role of Colorectal Cancer Stem Cells in Metastatic Disease and Therapeutic Response (Q37841141) (← links)
- Cell surface markers in colorectal cancer prognosis (Q37845669) (← links)
- Finding the root of the problem: the quest to identify melanoma stem cells (Q37881690) (← links)
- Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches. (Q37978771) (← links)
- CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges (Q38035206) (← links)
- New targets for the immunotherapy of colon cancer-does reactive disease hold the answer? (Q38089480) (← links)
- Biomarkers and signaling pathways of colorectal cancer stem cells (Q38354849) (← links)